Literature DB >> 8593321

Establishment of a bovine macrophage cell line from a fetal thymus.

K Yoshihara1, S Tanaka, Y Mori, Y Yokomizo, T Onodera, Y Hirota.   

Abstract

A cell line, FBM-17, was established from a fetal bovine thymus and passaged for more than a year. Electron microscopic examination revealed that the cytoplasm contained many phagosomes and a significant amount of rough endoplasmic reticula. In addition, FBM-17 cells showed non-specific esterase, phagocytosis and surface expression of Fc receptors for IgG and classes I and II MHC antigens. These observations confirmed that this cell line had the morphologic and functional features as a macrophage. MHC expression markedly increased by treatment with recombinant bovine gamma-interferon, showing the cell line to be sensitive to bovine gamma-interferon and functional. These present results suggest that the FBM-17 is a functional bovine macrophage cell line. This line gamma-interferon, showing the cell line to be useful for clarification of roles of macrophages in immunoregulation in cattle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593321     DOI: 10.1292/jvms.57.985

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

1.  Development and characterization of a continuous macrophage cell line, LRTM, derived from thymus of Labeo rohita (Hamilton 1822).

Authors:  Sanjay C Rebello; Gaurav Rathore; Peyush Punia; Neeraj Sood; V Elangovan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-17       Impact factor: 2.416

2.  Induction of nitric oxide production mediated by tumor necrosis factor alpha on staphylococcal enterotoxin C-stimulated bovine mammary gland cells.

Authors:  Ken-Ichi Komine; Toshinobu Kuroishi; Yumiko Komine; Kouichi Watanabe; Jin Kobayashi; Takahiro Yamaguchi; Shin-Ichi Kamata; Katsuo Kumagai
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Histophilus somni Survives in Bovine Macrophages by Interfering with Phagosome-Lysosome Fusion but Requires IbpA for Optimal Serum Resistance.

Authors:  Yu Pan; Yuichi Tagawa; Anna Champion; Indra Sandal; Thomas J Inzana
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.